Microbiota as a state-of-the-art approach in precision medicine for pancreatic cancer management: A comprehensive systematic review.

ABSTRACT: Emerging evidence suggests that harnessing the microbiome holds promise for innovative diagnostic and therapeutic strategies in the management of pancreatic cancer (PC). This study aims to systematically summarize the microbial markers associated with PC and assess their potential application in clinical outcome. Forty-one studies were included to assess the associations between microbial markers and PC. Among these, 13 were developed prediction models related to the microbiome in which the highest diagnostic and prognostic model belong to blood and intratumor markers, respectively. Notably, findings that utilize microbiotas from various body sites were elucidated, demonstrating their importance as unique signatures in biomarker discovery for diverse clinical applications. This review prov

SUBMITTER: Hesami Z 

PROVIDER: S-EPMC12019022 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature